Advertisement

An internal Genzyme Corp. memo, obtained by Mass High Tech, outlines a new employee retention program designed to keep workers from fleeing the company in the midst of layoffs and a potential hostile takeover by French drug maker Sanofi-aventis.

The letter from CEO Henri Termeer reads in part:

SOURCE

Advertisement
Advertisement